Combined Point-of-Care Nucleic Acid and Antibody Testing for SARS-CoV-2 following Emergence of D614G Spike Variant

Autor: Petra Mlcochova, Dami Collier, Allyson Ritchie, Sonny M. Assennato, Myra Hosmillo, Neha Goel, Bo Meng, Krishna Chatterjee, Vivien Mendoza, Nigel Temperton, Leo Kiss, Leo C. James, Katarzyna A. Ciazynska, Xiaoli Xiong, John A.G. Briggs, James A. Nathan, Federica Mescia, Laura Bergamaschi, Hongyi Zhang, Petros Barmpounakis, Nikos Demeris, Richard Skells, Paul A. Lyons, John Bradley, Steven Baker, Jean Pierre Allain, Kenneth G.C. Smith, Rachel Bousfield, Michael Wilson, Dominic Sparkes, Glenn Amoroso, Effrosyni Gkrania-Klotsas, Susie Hardwick, Adrian Boyle, Ian Goodfellow, Ravindra K. Gupta, Stephen Baker, Gordon Dougan, Ravi Gupta, Paul J. Lehner, Paul Lyons, Nicholas J. Matheson, Mark Toshner, Michael P. Weekes, Nick Brown, Martin Curran, Surendra Palmar, David Enoch, Daniel Chapman, Ashley Shaw, Sherly Jose, Areti Bermperi, Julie Ann Zerrudo, Evgenia Kourampa, Laura Watson, Jieniean Worsley, Caroline Saunders, Ranalie de Jesus, Jason Domingo, Ciro Pasquale, Bensi Vergese, Phoebe Vargas, Marivic Fabiculana, Marlyn Perales, Lee Mynott, Elizabeth Blake, Amy Bates, Anne-Laure Vallier, Alexandra Williams, David Phillips, Edmund Chiu, Alex Overhill, Nicola Ramenatte, Jamal Sipple, Steven Frost, Helena Knock, Richard Hardy, Emily Foster, Fiona Davidson, Viona Rundell, Purity Bundi, Richmond Abeseabe, Sarah Clark, Isabel Vicente, Anne Elmer, Carla Ribeiro, Jenny Kourampa, Jane Kennet, Jane Rowlands, Anne Meadows, Criona O’Brien, Rebecca Rastall, Cherry Crucusio, Sarah Hewitt, Jane Price, Jo Calder, Laura Canna, Ashlea Bucke, Hugo Tordesillas, Julie Harris, Valentina Ruffolo, Barbara Graves, Helen Butcher, Daniela Caputo, Emma Le Gresley, Benjamin J. Dunmore, Jennifer Martin, Ekaterina Legchenko, Carmen Treacy, Christopher Huang, Jennifer Wood, Rachel Sutcliffe, Josh Hodgson, Joy Shih, Stefan Graf, Zhen Tong, Tobias Tilly, Ciara O’Donnell, Kelvin Hunter, Linda Pointon, Nicole Pond, Marta Wylot, Emma Jones, Stuart Fawke, Ben Bullman, Lori Turner, Isobel Jarvis, Ommar Omarjee, Aloka De Sa, Joe Marsden, Ariana Betancourt, Marianne Perera, Maddie Epping, Nathan Richoz, Georgie Bower, Rahul Sharma, Francesca Nice, Oisin Huhn, Natalia Savoinykh Yarkoni, Nika Romashova, Daniel Lewis, Andrew Hinch, Chiara Cossetti, Mateusz Strezlecki, Richard Grenfell, Hannah Stark, Neil Walker, Kathy Stirrups, Nigel Ovington, Eleanor Dewhust, Emily Li, Sofia Papadia, Nathalie Kingston, Andrew Lever, Estee Torok, William Hamilton, Grant Hall, Aminu Jahun, Yasmin Chaudhry, Malte Pinckert, Iliana Georgana, Anna Yakovleva, Laura Caller, Sarah Caddy, Theresa Feltwell, Fahad Khokhar, Luke Meredith, Charlotte Holdcroft, Surendra Parmar

Publikováno v: Cell Reports Medicine, Vol 1, Iss 6, Pp 100099- (2020)

Summary: Rapid COVID-19 diagnosis in the hospital is essential, although this is complicated by 30%–50% of nose/throat swabs being negative by SARS-CoV-2 nucleic acid amplification testing (NAAT). Furthermore, the D614G spike mutant dominates the p

Externí odkaz: https://doaj.org/article/f56b9ae7c1d24d12996d40bd0463ae07

Early HIV treatment and survival over six years of observation in the ANRS 12249 Treatment as Prevention Trial

Autor: Kathy Baisley, Joanna Orne‐Gliemann, Joseph Larmarange, Melanie Plazy, Dami Collier, Jaco Dreyer, Thobeka Mngomezulu, Kobus Herbst, Willem Hanekom, Francois Dabis, Mark J. Siedner, Collins Iwuji

Publikováno v: HIV Medicine
HIV Medicine, 2022, 23 (8), pp.922-928. ⟨10.1111/hiv.13263⟩

International audience; Objectives: Population-based universal test and treat (UTT) trials have shown an impact on population-level virological suppression. We followed the ANRS 12249 TasP trial population for 6 years to determine whether the interve

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a890d50e664ece34b249f1af1e442fc
https://pubmed.ncbi.nlm.nih.gov/35218300

Feasibility and cost analysis of programmatic implementation of Microscopic-Observation Drug Susceptibility (MODS) assay in Nigeria

Autor: Ernest Afu, Ochang, Oyinlola O, Oduyebo, Ifeanyi A, Onwuezobe, Dami, Collier, Ibidunni, Bode-Sojobi, Michael, Odo

Publikováno v: Nigerian journal of medicine : journal of the National Association of Resident Doctors of Nigeria. 25(3)

Detection of Multi-drug resistant tuberculosis in Nigeria still remains a challenge. We evaluated the feasibility of programmatic implementation of the Microscopic-Observation Drug Susceptibility (MODS) assay, a rapid culture and drug susceptibility

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::85c55503e3c42f30602a8abfffb4a868
https://pubmed.ncbi.nlm.nih.gov/30011167

Translation from research to clinical practice: fostering improved patient care through microscopicobservation drug susceptibility for tuberculosis diagnosis in Nigeria

Autor: Oyin Oduyebo, Ibidunni Bode-Sojobi, Dami Collier, Ernest Ochang

Publikováno v: Annals of African medicine. 13(3)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::110ca08673dc26cdb9cff0c8a15dcb3d
https://pubmed.ncbi.nlm.nih.gov/24923377

Car windshield fragments as cheap alternative glass beads for homogenization of Mycobacterium tuberculosis cultures in a resource-limited setting

Autor: Ibidunni Bode-Sojobi, OO Oduyebo, Dami Collier, Rita O. Oladele, Ernest Afu Ochang

Publikováno v: International Journal of Mycobacteriology, Vol 3, Iss 1, Pp 46-49 (2014)

Tuberculosis is a global health problem which has been compounded by the emergence and rapid spread of drug resistant strains. Phenotypic drug susceptibility testing of Mycobacterium tuberculosis usually requires homogenization of cultures using 3–

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a781c7ddef61b9cba82c18b7396dfcb0